Vasilios Liapis

发表

Peroxidase enzymes inhibit osteoclast differentiation and bone resorption

A. Evdokiou, D. Leach, V. Panagopoulos, 2017, Molecular and Cellular Endocrinology.

Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs).

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2014, Anticancer research.

Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo

V. Ponomarev, A. Evdokiou, A. Zannettino, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model

V. Ponomarev, A. Evdokiou, D. Findlay, 2009, Clinical Cancer Research.

Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer

V. Ponomarev, A. Evdokiou, A. Zannettino, 2009, Molecular Cancer Therapeutics.

Uncovering a new role for peroxidase enzymes as drivers of angiogenesis.

A. Evdokiou, D. Leach, V. Panagopoulos, 2015, The international journal of biochemistry & cell biology.

APOMAB Antibody–Drug Conjugates Targeting Dead Tumor Cells are Effective In Vivo

M. Brown, O. Dolezal, J. J. Hou, 2018, Molecular Cancer Therapeutics.

Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2017, Cancer letters.

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2017, Cancer medicine.

Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2015, Cancer letters.

Zoledronic acid protects against osteosarcoma‐induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model

A. Evdokiou, D. Findlay, A. Labrinidis, 2010, International journal of cancer.

Systematic in vitro nanotoxicity study on anodic alumina nanotubes with engineered aspect ratio: understanding nanotoxicity by a nanomaterial model.

A. Evdokiou, D. Losic, Ye Wang, 2015, Biomaterials.

Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.

B. Coventry, A. Evdokiou, D. Findlay, 2006, Cancer research.

Tumour-associated macrophages process drug and radio-conjugates of the dead tumour cell-targeting APOMAB® antibody.

M. Brown, Nicole L. Wittwer, William Tieu, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Apo 2 L / TRAIL Inhibits Tumor Growth and Bone Destruction in aMurineModel of Multiple Myeloma

V. Ponomarev, A. Evdokiou, Sally K. Martin, 2009 .

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL

L. Butler, W. Tilley, A. Evdokiou, 2006, International journal of cancer.

Fc gamma receptor is not required for in vivo processing of radio- and drug-conjugates of the dead tumor cell-targeting monoclonal antibody, APOMAB®.

M. Brown, Nicole L. Wittwer, William Tieu, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human Osteoblasts

A. Evdokiou, V. Panagopoulos, D. Findlay, 2016, Calcified Tissue International.

Zoledronate Enhances the Cytotoxicity of Gamma Delta T Cell Immunotherapy in an Orthotopic Mouse Model of Osteolytic Osteosarcoma

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2018 .

Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma

V. Ponomarev, A. Evdokiou, A. Zannettino, 2009, Clinical Cancer Research.

Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.

V. Ponomarev, A. Evdokiou, D. Leach, 2017, International journal of oncology.

Therapeutic targeting of tumor hypoxia and necrosis with antibody α-radioconjugates

M. Brown, A. H. Staudacher, Vasilios Liapis, 2018, Antibody Therapeutics.

Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models

M. Brown, Nicole L. Wittwer, A. Evdokiou, 2020, Molecular Imaging and Biology.

Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®

M. Brown, Nicole L. Wittwer, William Tieu, 2020, EJNMMI Radiopharmacy and Chemistry.

An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer

Nicole L. Wittwer, P. Cardarelli, A. H. Staudacher, 2023, Journal for ImmunoTherapy of Cancer.

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2014, International journal of oncology.

Does Apo2L/TRAIL play any physiologic role in osteoclastogenesis?

A. Evdokiou, A. Zannettino, N. Sims, 2008, Blood.

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2016, Cancer Medicine.

Systematic in vitro nanotoxicity study on anodic alumina nanotubes with engineered aspect ratio: understanding nanotoxicity by a nanomaterial model.

A. Evdokiou, D. Losic, Ye Wang, 2015, Biomaterials.

Positron Emission Tomographic imaging of tumor cell death using Zirconium-89-labeled APOMAB® following cisplatin chemotherapy in lung and ovarian cancer xenograft models

Vasilios Liapis, 2020 .

Antibody drug conjugates: hitting the mark in pancreatic cancer?

Nicole L. Wittwer, A. H. Staudacher, Vasilios Liapis, 2023, Journal of Experimental & Clinical Cancer Research.

The RNA‐binding protein La/SSB associates with radiation‐induced DNA double‐strand breaks in lung cancer cell lines

M. Brown, A. H. Staudacher, Yanrui Li, 2021, Cancer reports.

Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models

M. Brown, Nicole L. Wittwer, A. Evdokiou, 2020, Molecular Imaging and Biology.

Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model

V. Ponomarev, A. Evdokiou, D. Findlay, 2009, Clinical Cancer Research.